Could this pill tame both depression and migraine? new study investigates

NCT ID NCT07579481

Recruiting now Symptom relief Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether the antidepressant vortioxetine can help people who suffer from both depression and migraine. Researchers will track 31 adults over 12 weeks to see if their mood and headache symptoms improve. The goal is to find a treatment that works for both conditions at once.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depression depressive disorder major depressive disorder migraine disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEPRESSION MIGRAINE

Contacts and locations

Locations

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Neurofisiopatologia
RECRUITING

Rome, Lazio, 00168, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.